You are viewing: China IVD Raw Material Market analysis
Part of: IVD Raw Material Market (Global)

The China IVD Raw Material Market was valued at $622.7 Million in 2026 and projected to reach to $954.1 Million by 2031, representing a compound annual growth rate of 8.9%. China's IVD raw material market is positioned for sustained growth through 2031, supported by government healthcare initiatives, increasing prevalence of chronic diseases, and expanding diagnostic testing infrastructure.

China IVD Raw Material Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China IVD Raw Material Market Trends and Insights

  • This represents a compound annual growth rate of 8.9%, outpacing global averages and reflecting China's strengthening position in diagnostic manufacturing and healthcare infrastructure development.
  • China's market growth is driven by increased domestic demand for diagnostic testing, rising healthcare expenditure, and the country's strategic focus on self-sufficiency in medical supply chains. The forecast period through 2031 underscores China's critical role in the Asia Pacific IVD raw material ecosystem.
  • China's expansion is supported by government initiatives promoting domestic innovation, growing laboratory automation, and rising prevalence of chronic diseases requiring routine diagnostic testing.
  • As China continues to invest in healthcare modernization and diagnostic capabilities, the country's IVD raw material market is positioned as a key growth engine within the region, attracting both domestic manufacturers and international suppliers seeking to capitalize on this expanding opportunity..

Key Market Statistics

  • CAGR (2026-2031) 8.9% CAGR
  • Market Size, 2026 ~USD 622.7 Million
  • Forecast, 2031 ~USD 954.1 Million
  • Country China

China IVD Raw Material Market Overview

Rapid Market Expansion :

China's IVD raw material market is growing at 8.9% CAGR, significantly outpacing the global rate of 7.7%, driven by increased domestic diagnostic manufacturing capacity and rising healthcare spending.

Strong Valuation Growth :

Market size is projected to expand from USD 622.7 million in 2026 to USD 954.1 million by 2031, representing a 53% increase over five years as China strengthens its position in diagnostic supply chains.

Healthcare Infrastructure Development :

China's ongoing investments in healthcare modernization, rural clinic expansion, and diagnostic center establishment are creating sustained demand for high-quality IVD raw materials across all regions.

Domestic Manufacturing Leadership :

China's emergence as a global IVD manufacturing hub is driving local raw material sourcing, reducing import dependency, and creating opportunities for both domestic suppliers and international partners.

China IVD Raw Material Market Dynamics

  • The market's 8.9% CAGR reflects China's strategic focus on self-sufficiency in diagnostic manufacturing and quality improvement standards.
  • Rising investments in precision medicine, COVID-19 surveillance systems, and preventive healthcare are accelerating demand for specialized raw materials.
  • Additionally, China's role as a manufacturing hub for global IVD companies ensures continued market dynamism and technological advancement in raw material formulations..

Market Ecosystem

logo-mobile

IVD RAW MATERIAL MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Supplies antibodies, antigens, recombinant proteins, enzymes, membranes, and other critical raw materials used in the development of immunoassays, molecular diagnostics, and point-of-care tests. Enables high assay sensitivity and specificity, ensures consistent test performance, and supports scalable diagnostic manufacturing.
company logo
Provides a broad portfolio of antibodies, proteins, enzymes, nucleic acids, and specialty reagents for diagnostic assay development and commercialization. Supports reliable assay development, improves diagnostic accuracy, and accelerates time-to-market for IVD manufacturers.
company logo
Develops and manufactures diagnostic-grade antibodies, antigens, and assay components for immunodiagnostic and rapid testing applications. Enhances assay performance, ensures batch-to-batch consistency, and supports high-quality diagnostic outcomes.
company logo
Offers recombinant proteins, antibodies, immunoassay reagents, and molecular diagnostic raw materials for clinical and research diagnostic applications. Provides high analytical sensitivity, supports biomarker detection, and enables development of advanced diagnostic tests.
company logo
Supplies integrated raw material solutions including antibodies, antigens, enzymes, and detection reagents for immunoassays and point-of-care diagnostics. Facilitates cost-effective assay development, improves diagnostic reliability, and supports large-scale manufacturing requirements.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's IVD raw material market is valued at USD 622.7 million in 2026, with projected growth to USD 954.1 million by 2031, representing an 8.9% CAGR.
    • China's market growth rate exceeds the global average of 7.7%, positioning the country as a high-growth region within the IVD raw material sector.
    • China's expansion is driven by government healthcare initiatives, rising diagnostic demand, and strategic investments in domestic manufacturing capabilities.
    • China's market represents a significant opportunity for both domestic and international suppliers seeking to serve the region's growing diagnostic testing infrastructure.

    IVD Raw Material Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026-2031
    Growth Rate CAGR of 7.7% from 2026 to 2031
    Largest Segment IVD MANUFACTURERS (End User)
    Market Size Base Year (Billions) ~USD 21.46 (2026)
    Revenue Forecast (Billions) ~USD 31.1 (2031)
    Segments Covered Product Type, Type, Technology, Application, Supply Source, Source/Origin, End User

    China IVD Raw Material Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product Type

    • Antibodies
    • Antigens & Proteins
    • Beads & Particles
    • Buffers & Diluents
    • Enzymes & Substrates
    • Labels & Detection Materials
    • Membranes
    • Oligonucleotides & Nucleic Acids
    • Other Products

    By Type

    • Academic & Research Institutes
    • Amplification Enzymes
    • Animal-Derived
    • Calibrators & Standards
    • Chemically Synthesized
    • Chemiluminescent Labels
    • Cho-Expressed
    • Colloidal Gold Conjugates
    • Cros
    • Detection Enzymes
    • E. Coli-Expressed
    • Fluorescent Dyes
    • Glass Fiber Pads
    • Gold Nanoparticles
    • Human-Derived
    • Ivd Manufacturers
    • Latex Particles
    • Magnetic Beads
    • Monoclonal Antibodies
    • Native Proteins
    • Nitrocellulose Membranes
    • Nylon & Pvdf Membranes
    • Other End Users
    • Pharmaceutical & Biotechnology Companies
    • Polyclonal Antibodies
    • Primers & Probes
    • Recombinant Antibodies
    • Recombinant Antigens
    • Substrates & Coenzymes
    • Synthetic Dna/Rna

    By Technology

    • Clinical Chemistry
    • Coagulation Testing
    • Flow Cytometry
    • Hematology
    • Immunoassay
    • Microbiology & Culture
    • Molecular Diagnostics
    • Other Technologies

    By Application

    • Autoimmune Diseases
    • Blood Screening
    • Cardiac Markers
    • Diabetes & Metabolic Disorders
    • Genetic & Rare Disease Testing
    • Infectious Diseases
    • Oncology/Cancer Markers
    • Other Applications
    • Women'S Health & Fertility

    By Supply Source

    • In-House Manufacturing
    • Third-Party Supply

    By Source/Origin

    • Biological/Natural Sources
    • Other Sources
    • Recombinant/ Synthetic Sources
    • Recombinant/Synthetic Sources

    By End User

    • Academic & Research Institutes
    • Cros
    • Ivd Manufacturers
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • IVD Raw Material Manufacturers : Suppliers need China-specific demand forecasts, customer requirements, and competitive benchmarking to optimize production capacity, pricing strategies, and market positioning in this high-growth region.
    • Diagnostic Equipment Manufacturers : OEMs require detailed insights into raw material availability, quality standards, and supplier landscape in China to secure reliable supply chains and reduce manufacturing costs for diagnostic devices.
    • Healthcare Investment Firms : Investors evaluating opportunities in China's diagnostic sector need market sizing, growth trajectories, and competitive dynamics to identify high-potential acquisition and partnership targets.
    • Healthcare System Operators : Hospital networks and diagnostic centers in China need market intelligence on raw material sourcing options, cost trends, and supplier capabilities to optimize procurement and service delivery.
    • Market Entry & Strategy Consultants : Consulting firms advising clients on China expansion require localized market data, regulatory insights, and competitive analysis to develop effective market entry and growth strategies.

    Reasons to Buy this Report

    • Localized Market Intelligence : Gain deep insights into China-specific growth drivers, regulatory landscape, and competitive dynamics that differ significantly from global market trends and require tailored business strategies.
    • Investment & Expansion Planning : Make informed decisions on market entry, facility location, and capacity planning with detailed forecasts showing 53% market growth potential through 2031 in China's high-growth diagnostic sector.
    • Supply Chain Optimization : Identify sourcing opportunities and supplier relationships in China's emerging IVD raw material ecosystem, critical for companies seeking to reduce costs and strengthen manufacturing resilience.
    • Competitive Positioning : Understand China's domestic manufacturers, international competitors, and market consolidation trends to develop effective go-to-market strategies and maintain competitive advantage in this fast-growing market.
    • Regulatory & Compliance Guidance : Navigate China's evolving quality standards, certification requirements, and healthcare policies specific to IVD raw materials to ensure market compliance and accelerate product approvals.

    Frequently asked questions

    What is the current size of China's IVD raw material market?

    China's IVD raw material market is valued at USD 622.7 million in 2026, with expectations to grow significantly through the forecast period.

    What is the projected market size for China's IVD raw materials by 2031?

    China's IVD raw material market is forecast to reach USD 954.1 million by 2031, representing substantial growth from the 2026 baseline.

    What is China's IVD raw material market CAGR?

    China's IVD raw material market is expected to grow at a compound annual growth rate of 8.9% between 2026 and 2031.

    How does China's market growth compare to global trends?

    China's 8.9% CAGR outpaces the global IVD raw material market CAGR of 7.7%, indicating China as a faster-growing region within the sector.

    What factors are driving growth in China's IVD raw material market?

    China's market growth is driven by increased healthcare spending, government support for domestic diagnostics manufacturing, rising disease prevalence, and laboratory automation expansion.

    RESEARCH METHODOLOGY

    The objective of this study is to analyze the key dynamics influencing the IVD raw material market, including drivers, restraints, opportunities, challenges, and emerging technology trends. The study also evaluates competitive developments, including product launches, regulatory approvals, acquisitions, partnerships, collaborations, and geographic expansions undertaken by leading market participants. Furthermore, it assesses the competitive landscape of the IVD raw material market by profiling key players and benchmarking them across various business and product strategy parameters. Both top-down and bottom-up approaches were employed to estimate the overall market size, while market breakdown and data triangulation methodologies were used to validate the size of individual segments and subsegments and ensure the accuracy of market estimates.

    The four steps involved in estimating the market size are as follows:

    Secondary Research

    Secondary research for the IVD raw material market drew on a wide range of credible commercial and regulatory sources, including Bloomberg Business, Factiva, and Dun & Bradstreet for corporate financial and operational data. White papers, scientific publications, annual reports, investor presentations, and SEC filings provided additional context on product pipelines, revenue structures, and market positioning. Regulatory databases were used to track device clearances and approvals in key geographies.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Supply-side primary interviews were conducted with project managers, product managers, sales directors, vice presidents of diagnostics, CEOs, and business development directors at manufacturers of IVD raw material, laboratory automation vendors, and IVD distributors. Demand-side primary interviews covered laboratory directors and clinical pathologists at hospital and reference laboratories, forensic laboratory managers, reproductive health clinic directors, academic research scientists, and procurement officers at pharmaceutical and biotechnology companies.

    The following is a breakdown of the primary respondents:

    IVD Raw Material Market Size, and Share

    Note: Others include sales, marketing, and product managers.
    Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    COMPANY NAME

    DESIGNATION

    Merck KGaA (Germany)

    Sales Manager

    Thermo Fisher Scientific Inc. (US)

    Product Manager

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the IVD raw material market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the IVD raw material market were determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    IVD Raw Material Market : Top-Down and Bottom-Up Approach

    IVD Raw Material Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size using the process described above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed to validate and complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments of the IVD raw material market. The data was triangulated by examining various factors and trends on the demand and supply sides of the IVD raw material market.

    Market Definition

    The IVD raw material market is the industry involved in the development, production, and supply of biological, chemical, and synthetic components used in manufacturing in vitro diagnostic (IVD) assays and testing systems. These raw materials include antibodies, antigens, proteins, enzymes, substrates, oligonucleotides, nucleic acids, beads and particles, membranes, labels and detection materials, buffers, diluents, and other specialized reagents that serve as critical building blocks for diagnostic tests. IVD raw materials are utilized across a wide range of diagnostic technologies. These materials play a vital role in ensuring the accuracy, sensitivity, specificity, and reliability of diagnostic tests used to detect, diagnose, screen for, monitor, and prognose health-related conditions.

    Key Stakeholders

    • IVD Raw Material Manufacturers and Suppliers
    • IVD Manufacturers (OEMs/Diagnostic Kit Manufacturers)
    • Contract Research Organizations (CROs) and Contract Development & Manufacturing Organizations (CDMOs)
    • Diagnostic Laboratories and Clinical Testing Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Research and Development (R&D) Centers
    • Distributors and Channel Partners
    • Regulatory and Quality Compliance Organizations
    • Healthcare Institutions and Diagnostic Service Providers

    Report Objectives

    • To define, describe, and forecast the IVD raw material market by product type, technology, application, supply source, source/origin, end user, and region
    • To provide detailed information about the key factors influencing the growth of the IVD raw material market (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide the competitive landscape details of the key players
    • To forecast the revenue of market segments across five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players of the IVD raw material market and comprehensively analyze their core competencies and market shares
    • To benchmark players within the market using the proprietary company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI on the market, along with the macroeconomic outlook for each region

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Country Information

    • Additional country-level analysis of the IVD raw material market

    Company Profiles

    • Additional five company profiles of players operating in the IVD raw material market.

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the IVD raw material market

    Get the Full IVD Raw Material Market Report

    Full forecast, segment splits, and company analysis for all IVD Raw Material Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status